Utilizing Biomarkers in Cancer Prevention, Diagnosis, and Treatment

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 90 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 39%
  • Publisher: 71%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

In this interview, Grace Liu from Sino Biological discusses the crucial role of biomarkers in cancer prevention and diagnosis and how they can help guide treatment decisions.

Sponsored Content by Sino Biological Inc.Oct 24 2023Reviewed by Maria Osipova insights from industryGrace LiuTechnical Account ManagerSino Biological In this interview, Grace Liu from Sino Biological discusses the crucial role of biomarkers in cancer prevention and diagnosis and how they can help guide treatment decisions.

Certain genetic biomarkers can be used to identify individuals with inherited gene mutations that increase their risk of developing certain types of cancer, such as BRCA1 and BRCA2 mutations in breast and ovarian cancer.1 Doctors can recommend preventive approaches such as increased surveillance, lifestyle modifications or even prophylactic surgeries to reduce the risk of developing cancer by detecting these genetic biomarkers.

In the context of cancer, biomarkers can be used to detect the presence of cancer cells, identify specific tumor types, determine the stage of the disease and predict the likelihood of response to certain treatments. Not only can biomarkers identify individuals who may be at a higher risk of developing cancer, but they can also help monitor the effectiveness of cancer treatments and detect any recurrence or progression.

What are the common methods and techniques employed for detecting biomarkers? There are various methods and techniques used to detect biomarkers, depending on the type of biomarker and the purpose of detection. Here are some common approaches: Well-validated and standardized assays or techniques to ensure accuracy and reliability are crucial for biomarker measurements for clinical and research applications.

About Grace Liu, Ph.D. Grace Liu, Technical Account Manager at Sino Biological US Inc., first joined Sino Biological back in 2022, supporting CRO services and project management in the western and central US regions. Grace received her Ph.D. in Medical Science from Baylor College of Medicine in Houston . Prior to joining Sino Biological, she worked at the Houston Methodist Research Institute as a postdoctoral fellow focused on sustained drug-eluting devices for cancer immunotherapy.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Linda Nolan is 'absolutely honoured' with new title amid cancer battleThe family have been affected by several cancer tragedies including the loss of Bernie in 2013 and earlier this year Linda, who had beaten cancer previously, revealed she had brain cancer.
Source: LiveLancs - 🏆 10. / 87 Read more »

Perioperative immunotherapy improves event-free survival in resectable early-stage lung cancerCompared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC).
Source: NewsMedical - 🏆 19. / 71 Read more »

Short course of induction chemotherapy can reduce cervical cancer relapse and death by 35%The INTERLACE phase III trial, funded by Cancer Research UK and UCL Cancer Trials Centre, assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could reduce the rate of relapse and death among patients with locally advanced cervical cancer.
Source: NewsMedical - 🏆 19. / 71 Read more »

Chemotherapy plus immunotherapy improves survival in patients with metastatic urothelial cancerA clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer.
Source: NewsMedical - 🏆 19. / 71 Read more »